RHY — Rhythm Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- AU$22.94m
- AU$19.74m
- AU$1.74m
Annual cashflow statement for Rhythm Biosciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.45 | 3.32 | 1.74 | 3.3 | 1.65 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.5 | -6.96 | -6.14 | -2.92 | -5.23 |
| Capital Expenditures | -0.027 | -0.099 | -0.082 | -0.023 | -0.026 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -0.56 | 0.003 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.027 | -0.099 | -0.082 | -0.583 | -0.023 |
| Financing Cash Flow Items | -0.468 | -0.024 | -0.118 | -0.219 | -0.536 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.8 | 3.63 | 2.8 | 4.19 | 7.22 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.32 | -3.43 | -3.41 | 0.688 | 1.96 |